SE7613775L - Fast komposition innehallande anti-hemofilfaktorfraktion och sett for dess framstellning - Google Patents

Fast komposition innehallande anti-hemofilfaktorfraktion och sett for dess framstellning

Info

Publication number
SE7613775L
SE7613775L SE7613775A SE7613775A SE7613775L SE 7613775 L SE7613775 L SE 7613775L SE 7613775 A SE7613775 A SE 7613775A SE 7613775 A SE7613775 A SE 7613775A SE 7613775 L SE7613775 L SE 7613775L
Authority
SE
Sweden
Prior art keywords
composition containing
solid composition
ahf
carbohydrate
hemofil
Prior art date
Application number
SE7613775A
Other languages
English (en)
Swedish (sv)
Inventor
W R Tomas
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of SE7613775L publication Critical patent/SE7613775L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE7613775A 1975-12-22 1976-12-08 Fast komposition innehallande anti-hemofilfaktorfraktion och sett for dess framstellning SE7613775L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64317875A 1975-12-22 1975-12-22

Publications (1)

Publication Number Publication Date
SE7613775L true SE7613775L (sv) 1977-06-23

Family

ID=24579687

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613775A SE7613775L (sv) 1975-12-22 1976-12-08 Fast komposition innehallande anti-hemofilfaktorfraktion och sett for dess framstellning

Country Status (3)

Country Link
US (1) US4089944A (fr)
BE (1) BE849366A (fr)
SE (1) SE7613775L (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
FR2613619B1 (fr) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
US5605884A (en) * 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
US5612320A (en) * 1993-12-22 1997-03-18 Internutria, Inc. Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
US5595772A (en) * 1995-06-07 1997-01-21 Massachusetts Institute Of Technology Composition and methods for losing weight
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
EP1820516B1 (fr) * 1999-02-22 2013-07-24 University of Connecticut Nouvelles formulations de facteur VIII sans albumine
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
EP2385825B1 (fr) 2008-11-07 2018-10-10 University of Connecticut Formulation de facteur viii
WO2019074886A1 (fr) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc Récipient de lyophilisation et son procédé d'utilisation
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826533A (en) * 1954-03-15 1958-03-11 Cutter Lab Stable fibrinogen solutions and method for producing same
US3057781A (en) * 1956-02-23 1962-10-09 U S Pharmaceutical Inc Stabilization of plasma with invert sugar
US3803115A (en) 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor

Also Published As

Publication number Publication date
US4089944A (en) 1978-05-16
BE849366A (fr) 1977-04-01

Similar Documents

Publication Publication Date Title
SE7903817L (sv) Moranolinderivat
HUT43786A (en) Process for production of medical compounds with increased giving down of the active substance
FR2590501B1 (fr) Composition absorbant les liquides
GR76810B (fr)
FI820808L (fi) Stabiliserade insulinpreparat och foerfarande foer framstaellning av dessa
GR78416B (fr)
SE8204874L (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
AU541247B2 (en) Adjuvants for rectal delivery of drug substances
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
SE7900774L (sv) Stabilsteril vattenlosning av cisplatin
JPS56138111A (en) Suppository containing unsaturated fatty acid or salt thereof
FR2607702B1 (fr) Solutions injectables pretes a l'emploi contenant un agent anti-tumeur du type anthracycline-glucoside
JPS57163315A (en) Preventing agent and remedy for thrombosis
JPS56138110A (en) Suppository containing citric acid or salt thereof
SE8200591L (sv) Forfarande for framstellning av en komposition omfattande ett lyofiliserat penicillinderivat
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
KR830009776A (ko) 세포 보호 유도방법
JPS53130421A (en) Remedy for uterine cancer and its preparation
Thomson et al. Acetylation of p-aminobenzoic acid in X-irradiated rats
JPS5665079A (en) Stabilization of ground
SE9302006D0 (sv) Protein formulation
JPS567720A (en) Antiphlogistic agent
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
HURLEY A dental depot in penicillin hypersensitivity

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7613775-1